Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages
about
Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we goArray-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K).Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridizationGenomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.Array comparative genomic hybridization analysis identifies recurrent gain of chromosome 2p25.3 involving the ACP1 and MYCN genes in chronic lymphocytic leukemia.Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies.The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications.Chronic lymphocytic leukemia: Time to go past genomics?Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups.Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.Chronic lymphocytic leukaemia genomics and the precision medicine era.Array comparative genomic hybridization detects chromosomal abnormalities in hematological cancers that are not detected by conventional cytogenetics.Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia.Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1.Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics.Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescencein situhybridization techniques?Combined somatic mutation and copy number analysis in the survival of familial CLL
P2860
Q33274900-414C1B42-34EE-40C4-96DD-E5D0A6E060FDQ33744997-65248912-4C2A-44D3-8DB6-99812B192149Q35143490-E0436FE7-A4E8-4B26-AC41-B0E1DE5D4479Q35650512-1D9F2E81-E688-4D26-ADE8-2C9496392697Q36433299-A788457B-7A3B-412C-8E24-539781BD1FE9Q36520447-D3D4DF0B-D399-4082-92E3-4E6EF3492902Q36644914-C4BCC008-FE9E-4F84-9B4E-7F40586A2471Q36651908-2DE422E3-D921-4144-A6DE-2585273AEF3FQ36799831-9B9B18B8-6D7B-4E88-BE80-33717E10114EQ36837347-2F2FDE56-0E3F-4053-9032-A09B83DAE094Q38061177-DEBAA719-3A24-4E3A-9BD5-FAF95E0D0482Q38286344-AE2E741B-5195-468A-BF42-870E4942B8B2Q38708220-A28297C3-437E-4965-AFFE-B5F7B90D633DQ38742049-9ECE6DAA-1D4A-403B-AD49-B85EF4EA5860Q38744632-E7EA9AC5-73F3-4511-B543-A7CD3B4A34E5Q39263974-46B3B5AE-A922-4818-BAD8-182B90FCE2B9Q42479122-E5BD4785-19F7-4EF4-AD42-1CAB30EB69A2Q44447816-529824AB-654D-4CCB-AFC5-C8D2A94B2FF5Q51548976-5270BA29-1E90-453D-88DA-967E7A9E4752Q53746177-32D3A32B-1131-4CAF-A21D-18F14E5AD46AQ55057300-C2F34A72-DB87-4E11-A92A-0534D9F8C4ACQ58010100-0833FBFF-9694-4F1A-9EDC-7987864AA36DQ58277186-F107153D-9560-4ABF-95C3-F3698ABC071E
P2860
Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages
description
article
@en
im April 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2010
@uk
name
Gain of the short arm of chrom ...... kemia (CLL) at advanced stages
@en
Gain of the short arm of chromosome 2
@nl
type
label
Gain of the short arm of chrom ...... kemia (CLL) at advanced stages
@en
Gain of the short arm of chromosome 2
@nl
prefLabel
Gain of the short arm of chrom ...... kemia (CLL) at advanced stages
@en
Gain of the short arm of chromosome 2
@nl
P2093
P50
P1433
P1476
Gain of the short arm of chrom ...... kemia (CLL) at advanced stages
@en
P2093
Christian Bastard
Christine Terré
Claude Lesty
Dominique Leroux
Elise Chapiro
Evelyne Callet-Bauchu
Françoise Brizard
Frédéric Davi
Hossein Mossafa
Isabelle Radford-Weiss
P356
10.1016/J.LEUKRES.2009.03.042
P577
2009-04-29T00:00:00Z